Medine Giynas Ayhan1, Faruk Uguz2, Rustem Askin3, Mehmet Sait Gonen4. 1. Department of Psychiatry, Aksehir State Hospital, Konya, Turkey. Electronic address: drmedineayhan@gmail.com. 2. Department of Psychiatry, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey. 3. Department of Psychiatry, Sevket Yilmaz Education and Research Hospital, Bursa, Turkey. 4. Department of Internal Medicine, Division of Endocrinology, University of Necmettin Erbakan, Meram Faculty of Medicine, Konya, Turkey.
Abstract
OBJECTIVE: The aim of this study was to examine the current prevalence of major depression and anxiety disorders in patients with euthyroid Hashimoto's thyroiditis (HT) and euthyroid goiter. METHOD: The study sample was formed by consecutive 51 and 45 patients who were admitted to the endocrinology outpatient clinic and diagnosed with euthyroid HT and endemic/nonendemic goiter, respectively, and 68 healthy controls. Current diagnoses of psychiatric disorders were determined using the Structured Clinical Interview for DSM-IV. Beck Depression Inventory and Beck Anxiety Inventory were applied to the participants. RESULTS: There was a statistically significant difference among the three groups in terms of major depression (P=.001), any mood or anxiety disorder (P=.000), any depressive disorder (P=.020), any anxiety disorder (P=.016) and obsessive-compulsive disorder (OCD) (P=.013). In the HT group, the prevalence of depression (P=.000), OCD (P=.005) and panic disorder (P=.041) was significantly higher than that in the control group. In the goiter group, depression (P=.006), any depressive disorder (P=.03), and any mood or anxiety disorder (P=.000) were significantly common in comparison to the control group. No significant difference was found between the HT and goiter groups. CONCLUSIONS: Euthyroid HT and euthyroid goiter increase predisposition to major depression and anxiety disorders, and thyroid autoimmunity and other thyroid pathologies should be investigated in euthyroid patients with chronic and treatment-resistant complaints.
OBJECTIVE: The aim of this study was to examine the current prevalence of major depression and anxiety disorders in patients with euthyroid Hashimoto's thyroiditis (HT) and euthyroid goiter. METHOD: The study sample was formed by consecutive 51 and 45 patients who were admitted to the endocrinology outpatient clinic and diagnosed with euthyroid HT and endemic/nonendemic goiter, respectively, and 68 healthy controls. Current diagnoses of psychiatric disorders were determined using the Structured Clinical Interview for DSM-IV. Beck Depression Inventory and Beck Anxiety Inventory were applied to the participants. RESULTS: There was a statistically significant difference among the three groups in terms of major depression (P=.001), any mood or anxiety disorder (P=.000), any depressive disorder (P=.020), any anxiety disorder (P=.016) and obsessive-compulsive disorder (OCD) (P=.013). In the HT group, the prevalence of depression (P=.000), OCD (P=.005) and panic disorder (P=.041) was significantly higher than that in the control group. In the goiter group, depression (P=.006), any depressive disorder (P=.03), and any mood or anxiety disorder (P=.000) were significantly common in comparison to the control group. No significant difference was found between the HT and goiter groups. CONCLUSIONS: Euthyroid HT and euthyroid goiter increase predisposition to major depression and anxiety disorders, and thyroid autoimmunity and other thyroid pathologies should be investigated in euthyroid patients with chronic and treatment-resistant complaints.
Authors: Eva-Maria Siegmann; Helge H O Müller; Caroline Luecke; Alexandra Philipsen; Johannes Kornhuber; Teja Wolfgang Grömer Journal: JAMA Psychiatry Date: 2018-06-01 Impact factor: 21.596
Authors: Aniceta A Mikulska; Marta Karaźniewicz-Łada; Dorota Filipowicz; Marek Ruchała; Franciszek K Główka Journal: Int J Mol Sci Date: 2022-06-13 Impact factor: 6.208
Authors: Daniel S Tylee; Jiayin Sun; Jonathan L Hess; Muhammad A Tahir; Esha Sharma; Rainer Malik; Bradford B Worrall; Andrew J Levine; Jeremy J Martinson; Sergey Nejentsev; Doug Speed; Annegret Fischer; Eric Mick; Brian R Walker; Andrew Crawford; Struan F A Grant; Constantin Polychronakos; Jonathan P Bradfield; Patrick M A Sleiman; Hakon Hakonarson; Eva Ellinghaus; James T Elder; Lam C Tsoi; Richard C Trembath; Jonathan N Barker; Andre Franke; Abbas Dehghan; Stephen V Faraone; Stephen J Glatt Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2018-10-16 Impact factor: 3.568
Authors: Benjamín Romero-Gómez; Paula Guerrero-Alonso; Juan Manuel Carmona-Torres; Blanca Notario-Pacheco; Ana Isabel Cobo-Cuenca Journal: Int J Environ Res Public Health Date: 2019-11-28 Impact factor: 3.390